GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Other Stockholders Equity

Renata (DHA:RENATA) Other Stockholders Equity : BDT723 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Renata Other Stockholders Equity?

Renata's Other Stockholders Equity for the quarter that ended in Dec. 2023 was BDT723 Mil.

Renata's quarterly Other Stockholders Equity increased from Jun. 2023 (BDT724 Mil) to Sep. 2023 (BDT724 Mil) but then declined from Sep. 2023 (BDT724 Mil) to Dec. 2023 (BDT723 Mil).

Renata's annual Other Stockholders Equity increased from Jun. 2021 (BDT135 Mil) to Jun. 2022 (BDT399 Mil) and increased from Jun. 2022 (BDT399 Mil) to Jun. 2023 (BDT724 Mil).

Renata Other Stockholders Equity Historical Data

The historical data trend for Renata's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata Other Stockholders Equity Chart

Renata Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 255.31 171.14 135.07 398.78 723.58

Renata Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 395.90 427.30 723.58 723.60 723.46

Renata Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Renata Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Renata's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Renata (DHA:RENATA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Other Stockholders Equity
Comparable Companies
DHA:SQURPHARMA DHA:BXPHARMA DHA:BEACONPHAR DHA:ACMELAB DHA:ORIONINFU DHA:AFCAGRO ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX
Traded in Other Exchanges
N/A
Address
Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Website
https://www.renata-ltd.com
Renata Ltd is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata (DHA:RENATA) Headlines

No Headlines